Cilostazol Tablet
NDC Package 84386-002-60

11-digit billing NDC: 84386000260
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Cilostazol tablets are indicated for the reduction of symptoms of intermittent claudication, as demonstrated by an increased walking distance. This formulation utilizes a tablet delivery system. Marketed by Aurobindo Pharma Limited, this product is identified by NDC 84386-002 and is authorized under FDA application ANDA077019.

Identification & Billing

NDC Package Code
84386-002-60
Package Description
60 TABLET in 1 BOTTLE
Product Code
84386-002
11-Digit Billing Format
84386000260

Clinical Specifications

Proprietary Name
Cilostazol
Non-Proprietary Name
Cilostazol
Substance Name
Cilostazol
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
CILOSTAZOL 50 mg/1
Pharmacologic Class
Usage Information
Cilostazol tablets are indicated for the reduction of symptoms of intermittent claudication, as demonstrated by an increased walking distance.

Regulatory & Marketing

Labeler Name
Aurobindo Pharma Limited
Product Type
Human Prescription Drug
FDA Application #
ANDA077019
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
09-03-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 84386-002-60 identifies a specific commercial package of 60 tablet in 1 bottle of Cilostazol, a human prescription drug labeled by Aurobindo Pharma Limited. This tablet is formulated for oral use and contains cilostazol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Aurobindo Pharma Limited on September 03, 2026. The current certification is valid through December 31, 2027.

How is this Aurobindo Pharma Limited product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 84386000260. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
84386-002-60
11-Digit CMS (5-4-2)
84386-0002-60

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.